University of Fukui Hospital

Fukui 9101193

2 studies enrolling now · 4 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Follicular Lymphoma, Large B-cell Lymphoma, Leukemia, Myeloid, Acute, Newly Diagnosed Acute Myeloid Leukemia (AML), Small Lymphocytic Lymphoma, Untreated AML

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel — Available (expanded access)
• A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) — Running, not enrolling